Announces CAEL-101 Strategic Partnership with Alexion Pharmaceut

Education

Fortress Biotech, Inc. (NASDAQ:FBIO)

NASDAQ:FBIO Fortress Biotech, Inc.

trendanalysis harmonicpatterns chartpattern

Fortress-founded Caelum Biosciences to receive $60 million in a strategic equity investment and option fee

Alexion has option to acquire Caelum Biosciences based on Phase 2 data

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.